| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 9,913 | 9,629 | 8,843 | 10,020 | | Cost of Revenue | 3,436 | 3,466 | 3,110 | 3,110 | | | Gross Profit | 6,477 | 6,163 | 5,733 | 6,910 | | | Operating Expenses | | Research Development | 919 | 686 | 695 | 797 | | Selling General and Administrative | 3,578 | 3,341 | 3,320 | 3,849 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 354 | 341 | 327 | 409 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,626 | 1,795 | 1,391 | 1,855 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (748) | (479) | (160) | 623 | | Earnings Before Interest And Taxes | 1,853 | 1,316 | 1,231 | 2,478 | | Interest Expense | 145 | 161 | 257 | 274 | | Income Before Tax | 1,708 | 1,155 | 974 | 2,204 | | Income Tax Expense | 380 | 53 | 5 | 399 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,328 | 1,102 | 969 | 1,805 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,328 | 1,102 | 969 | 1,805 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,328 | $1,102 | $969 | $1,805 |
|
0.34% Nasdaq 0.00%
Income Statement
